Auteur/autrice : oxeltis
Biofit strasbourg (FR), Nov 29-30, 2022
We are excited to catch up with you at Biofit’s networking event Strasbourg very soon!At Oxeltis, we focus on accelerating our client's medchem research through a diverse range of services. (...)
International Round table on nucleosides, nucleotides and nucleic acids
Oxeltis is a sponsor of next IRT meeting in Stockholm (Aug 28-31, 2022) . Book a meeting with Oxeltis scientists and Visit our booth!
37th ACS Medicinal chemistry symposium June 26-29th, 2022
Oxeltis will be present at the 37th ACS National Medicinal Chemistry Symposium in NY June 26-29th. We are very happy to meet you soon, come and visit our poster booth#1 (...)
Lead Pharma and oxeltis receive €800K Eureka euristars grant
Grant will fund three-year EPIGENEXT joint project aimed at developing first-in-class therapy for diffuse large B-cell lymphoma Oss, the Netherlands and Montpellier, France, June 8, 2022 – Lead Pharma, a (...)
Oxeltis online at AIMECS 2021, 29 Nov – 02 Dec.
Organized by the Asian Federation for Medicinal Chemistry (AFMC), AIMECS 2021 (AFMC International Medicinal Chemistry Symposium 2021) is a major event in medicinal chemistry in Asia.Oxeltis, a medicinal chemistry service (...)
IS3NA – IRT 2021, August 26-27
Oxeltis is happy to participate and sponsor IS3NA-IRT 2021 Virtual meeting. Looking forward contacting you about your nucleos(t)ides medchem and custom synthesis programs. https://www.is3na.org/events-1/2021-virtual-symposium
GECO 2021 – 25 au 27 août 2021
Oxeltis est heureux de participer et de sponsoriser le GECO 2021. Retrouvez-nous pour tous besoins de ressources externes sur vos programmes de chimie médicinale et de synthèse à façon. https://geco61.sciencesconf.org/